Last updated on February 2018

Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency

Brief description of study

To evaluate the safety and efficacy of PEG Somatropin Injection (Jintrolong) in the treatment of short stature due to endogenous growth hormone deficiency (GHD) in the broad of population of children.

Clinical Study Identifier: NCT02908958

Contact Investigators or Research Sites near you

Start Over

Wei Liao, MD

Southwest Hospital, Third Military Medical University
Chongqing, China
  Connect »